1. Home
  2. ANTA vs TVRD Comparison

ANTA vs TVRD Comparison

Compare ANTA & TVRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANTA
  • TVRD
  • Stock Information
  • Founded
  • ANTA 2022
  • TVRD 2017
  • Country
  • ANTA Singapore
  • TVRD United States
  • Employees
  • ANTA N/A
  • TVRD N/A
  • Industry
  • ANTA Investment Bankers/Brokers/Service
  • TVRD Biotechnology: Pharmaceutical Preparations
  • Sector
  • ANTA Finance
  • TVRD Health Care
  • Exchange
  • ANTA Nasdaq
  • TVRD Nasdaq
  • Market Cap
  • ANTA 291.0M
  • TVRD 246.5M
  • IPO Year
  • ANTA 2025
  • TVRD N/A
  • Fundamental
  • Price
  • ANTA $9.92
  • TVRD $4.13
  • Analyst Decision
  • ANTA Strong Buy
  • TVRD Buy
  • Analyst Count
  • ANTA 3
  • TVRD 7
  • Target Price
  • ANTA $17.50
  • TVRD $51.67
  • AVG Volume (30 Days)
  • ANTA 8.2K
  • TVRD 242.3K
  • Earning Date
  • ANTA 11-10-2025
  • TVRD 11-13-2025
  • Dividend Yield
  • ANTA N/A
  • TVRD N/A
  • EPS Growth
  • ANTA 669.18
  • TVRD N/A
  • EPS
  • ANTA 0.47
  • TVRD N/A
  • Revenue
  • ANTA $65,033,103.00
  • TVRD N/A
  • Revenue This Year
  • ANTA $65.94
  • TVRD N/A
  • Revenue Next Year
  • ANTA $59.39
  • TVRD N/A
  • P/E Ratio
  • ANTA $20.13
  • TVRD N/A
  • Revenue Growth
  • ANTA 63.28
  • TVRD N/A
  • 52 Week Low
  • ANTA $9.03
  • TVRD $3.85
  • 52 Week High
  • ANTA $27.72
  • TVRD $43.65
  • Technical
  • Relative Strength Index (RSI)
  • ANTA N/A
  • TVRD 21.32
  • Support Level
  • ANTA N/A
  • TVRD $3.87
  • Resistance Level
  • ANTA N/A
  • TVRD $4.45
  • Average True Range (ATR)
  • ANTA 0.00
  • TVRD 0.31
  • MACD
  • ANTA 0.00
  • TVRD 1.01
  • Stochastic Oscillator
  • ANTA 0.00
  • TVRD 25.22

About ANTA Antalpha Platform Holding Company Ordinary Shares

Antalpha Platform Holding Co provides financing, technology and risk management solutions to the digital asset industry. It is a provider of supply chain financing solutions to institutional and corporate participants in the Bitcoin mining industry, offering loans secured by Bitcoin and Bitcoin mining machines. It has developed a technology platform, Antalpha Prime, which enables customers to apply for and manage their digital asset loans while allowing to closely monitor collateral positions.

About TVRD Tvardi Therapeutics Inc. Common Stock

Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.

Share on Social Networks: